3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Motor Activity
13
Breast Neoplasms
13
Fatigue
6
Neoplasms
4
Lymphedema
4
Depression
4
Neoplasm Metastasis
3
Multiple Myeloma
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Breast Cancer Lymphedema
3
Anxiety Disorders
3
Respiratory Aspiration
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Hypoventilation
2
Ventricular Dysfunction, Left
1
Uterine Cervical Neoplasms
1
Trismus
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Tumor Cancer
1
Sarcoma
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Pain
1
Osteosclerosis
1
Osteoarthritis, Knee
1
Interventions
Paclitaxel
7
Oxaliplatin
6
Vincristine
4
Radiotherapy
4
Leucovorin
4
Carboplatin
4
Amifostine
4
Taxes
3
Sodium Chloride
3
Procarbazine
3
Methotrexate
3
Fluorouracil
3
Cytarabine
3
xaliproden
2
glucarpidase
2
Rituximab
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Prednisolone
2
Magnesium Sulfate
2
Duloxetine Hydrochloride
2
Dexamethasone
2
Cyclophosphamide
2
Cisplatin
2
Calcium Gluconate
2
Acupuncture Therapy
2
neurotropin
1
motexafin gadolinium
1
haloperidol decanoate
1
glutamic acid diethyl ester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neurotoxicity Syndromes
×
Exercise Therapy
×
Clear all
NCT04583124
2025-11-18
ATENTO
Universidad de Granada
Phase NA
Completed
42 enrolled